Evidence map›Paper›PMID 36552582›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Gentirigeoside B from

Lan Xiang, Dejene Disasa, Yanan Liu, Rui Fujii, Mengya Yang, Enchan Wu, Akira Matsuura, Jianhua Qi

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Quality Evaluation and Antioxidant Activity of CultivatedMolecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Review
  6. An Integrated Strategy for Investigating Antioxidants fromAntioxidants (Basel, Switzerland) · 2023
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lan XiangCollege of Pharmaceutical Science, Zhejiang University, 866 Yu Hang Road, Hangzhou 310058, China.
Dejene DisasaCollege of Pharmaceutical Science, Zhejiang University, 866 Yu Hang Road, Hangzhou 310058, China.ORCID 0000-0002-1920-5079
Yanan LiuCollege of Pharmaceutical Science, Zhejiang University, 866 Yu Hang Road, Hangzhou 310058, China.
Rui FujiiDepartment of Biology, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.
Mengya YangCollege of Pharmaceutical Science, Zhejiang University, 866 Yu Hang Road, Hangzhou 310058, China.
Enchan WuCollege of Pharmaceutical Science, Zhejiang University, 866 Yu Hang Road, Hangzhou 310058, China.ORCID 0000-0001-6158-0537
Akira MatsuuraDepartment of Biology, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.ORCID 0000-0002-2300-7227
Jianhua QiCollege of Pharmaceutical Science, Zhejiang University, 866 Yu Hang Road, Hangzhou 310058, China.

Funding

National Key R&D Program of China 2019YFE0100700National Natural Science Foundation of China 21877098, 22177102
6 · The paper itself

Abstract

Gentirigeoside B (GTS B) is a dammaren-type triterpenoid glycoside isolated from

Indexed as

autophagyGentirigeoside BG. rigescens Franchlongevityoxidative stressTORC1 signaling pathway

Identifiers

PMID36552582
PMCPMC9774393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.